MedTrace Logo

Attention to Incentives

NCT02411058 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2055

Last updated 2015-10-12

No results posted yet for this study

Summary

In this experiment, the investigators will test the effectiveness of a two week 20x incentive multiplier on the investigators' corporate partner's users who are (a) not notified about the incentives in advance, and (b) notified about the incentives and their purpose. The investigators will test which group shows the largest boost in walking during the two week intervention and the most lasting behavior change.

Conditions

  • Informed and Uninformed Incentives

Interventions

BEHAVIORAL

Uninformed

Users will receive 20x their usual incentives for two weeks, but will either receive no emails informing them about the incentive program.

BEHAVIORAL

Informed

Users will receive 20x their usual incentives for two weeks, and they will receive emails informing them about the incentives (one announcement before the incentives begin, and one email every two days reminding them about the overall incentive program). These emails will contain information about the incentives and the purpose of the incentives. The reminder emails sent every two days, however, will include more information about the overall program incentives to maximize the number of participants who learn about the incentive program at some point.

Sponsors & Collaborators

Principal Investigators

  • Katherine L. Milkman, Ph.D. · University of Pennsylvania

  • Bradford Tuckfield · University of Pennsylvania

  • Francesco Gino, Ph.D. · HBS

  • Leslie K. John, Ph.D. · HBS

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02411058 on ClinicalTrials.gov